Doximity (DOCS)
(Delayed Data from NYSE)
$40.88 USD
+0.25 (0.62%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $40.89 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Income Statements
Fiscal Year end for Doximity, Inc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 475 | 419 | 344 | 207 | 116 |
Cost Of Goods | 51 | 53 | 40 | 31 | 15 |
Gross Profit | 425 | 366 | 304 | 176 | 101 |
Selling & Adminstrative & Depr. & Amort Expenses | 261 | 240 | 190 | 122 | 79 |
Income After Depreciation & Amortization | 164 | 125 | 114 | 53 | 22 |
Non-Operating Income | 21 | 8 | 0 | 4 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 185 | 133 | 114 | 58 | 24 |
Income Taxes | 38 | 20 | -41 | 8 | -6 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 148 | 113 | 155 | 50 | 30 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 148 | 113 | 155 | 50 | 30 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 178 | 147 | 133 | 66 | 28 |
Depreciation & Amortization (Cash Flow) | 14 | 22 | 19 | 12 | 6 |
Income After Depreciation & Amortization | 164 | 125 | 114 | 53 | 22 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 205.73 | 213.43 | 191.02 | NA | NA |
Diluted EPS Before Non-Recurring Items | 0.77 | 0.55 | 0.69 | NA | NA |
Diluted Net EPS (GAAP) | 0.72 | 0.53 | 0.70 | 0.23 | NA |
Fiscal Year end for Doximity, Inc falls in the month of March .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 126.68 | 118.06 | 135.28 | 113.61 | 108.47 |
Cost Of Goods | 13.55 | 12.57 | 12.19 | 12.76 | 13.15 |
Gross Profit | 113.13 | 105.49 | 123.09 | 100.85 | 95.32 |
SG&A, R&D, and Dept/Amort Expenses | 67.07 | 63.64 | 64.55 | 67.06 | 65.63 |
Income After SG&A, R&D, and Dept/Amort Expenses | 46.06 | 41.85 | 58.54 | 33.79 | 29.69 |
Non-Operating Income | 7.12 | 6.10 | 4.48 | 5.90 | 4.84 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 53.17 | 47.95 | 63.03 | 39.70 | 34.52 |
Income Taxes | 11.79 | 7.33 | 15.08 | 9.09 | 6.12 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 41.38 | 40.62 | 47.96 | 30.60 | 28.41 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 41.38 | 40.62 | 47.96 | 30.60 | 28.41 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 199.22 | 201.11 | 200.46 | 209.01 | 212.36 |
Diluted EPS Before Non-Recurring Items | 0.22 | 0.20 | 0.25 | 0.18 | 0.14 |
Diluted Net EPS (GAAP) | 0.21 | 0.20 | 0.24 | 0.15 | 0.13 |